Wellcome Trust's Q1 2026 13F Is a 21-Stock Quality-Core Portfolio

WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST gave investors a useful Q4 2025 case study in why 13F work should start with structure, not with a single headline holding. Wellcome Trust reported $8.09B in 2026Q1 13F value across 21 holdings, led by V, AAPL, AMZN and MSFT. The result is not a simple buy-or-sell story. It is a map of where a very large reporting book kept its core exposure, where it trimmed, and which parts of the portfolio deserve a second look before anyone calls the filing a conviction signal.

The first screen is familiar: V, AAPL, AMZN, MSFT, GOOGL, GOOG, MA, CSCO, DASH, JNJ. Those names dominate most large institutional filings because they dominate US market capitalization. The differentiated work is in the share-count changes, the concentration math, and the distinction between an allocator's benchmark exposure and a stock picker's fresh thesis. That is where this filing becomes more useful than a top-ten table.

What the top holdings actually say

The top-holdings chart shows the scale problem clearly. A multi-billion-dollar line can be important without being a new view, and a reduced share count can still leave the position among the largest exposures in the book. For WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, the sensible read is to separate the portfolio's market backbone from the few places where the filing shows a visible change.

• V led at $725.4M and 9.0%, narrowly ahead of AAPL at $710.6M and AMZN at $687.3M.
• The top ten reached about 70.3%, making this a genuinely concentrated trust portfolio.
• AUM fell from $9.32B in 2025Q4 to $8.09B in 2026Q1 while holdings count stayed at 21.
• The book mixes payments, mega-cap platforms, Berkshire, Cisco, DoorDash and healthcare.

That distinction matters for retail investors using 13F data. Copying the largest line is usually the least informative action because it may simply reflect index weight, client allocation, derivatives hedging, or a broad benchmark sleeve. The better question is whether the manager changed the exposure in a way that is large enough to survive normal market drift. In this filing, the answer is mixed: the mega-cap core is still there, but the individual changes point to selective adjustments rather than a wholesale rotation.

Concentration is the real risk signal

The concentration chart is more important than the ranking table. If the top ten consume most of a filing, the manager's public equity risk is driven by a narrow set of names. If the top ten are only a minority, the headline stocks can overstate the actual portfolio signal. Here, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST remains large enough that even the biggest holdings need to be read against a broad tail.

That tail is not filler. It is the part of the 13F that keeps a mega-filer from behaving like a concentrated hedge fund. It can include sector sleeves, country exposure, ETFs, client-driven positions, and ordinary benchmark maintenance. The visible top-ten names still matter, especially NVDA, AAPL, and MSFT, but they do not tell the whole story alone.

How to use this filing now

The forward-looking checklist is concrete. First, compare the next 13F deadline, 45 days after quarter-end, against the share-count changes in the names above. Second, check whether the largest reductions reverse or continue. Third, use the stock pages for NVDA, TSLA, META, and GOOGL to see whether other active holders moved in the same direction. A single mega-filer is a clue; a cluster of active managers is a stronger signal.

For this quarter, the clean conclusion is that WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST remained anchored in the US mega-cap complex while the details showed selective risk management. That is exactly the kind of filing where investors should resist a simplistic "bought tech" headline and instead ask which positions changed, which stayed flat, and which parts of the disclosed book are just the cost of being a very large global holder.

One more guardrail belongs in the workflow. A 13F is a delayed snapshot, not a live portfolio. The Q4 2025 report reflects positions as of December 31, 2025, and the public release arrives after the statutory filing window. That lag does not make the filing useless, but it changes how it should be used. Treat the data as evidence of how the manager entered the next quarter, then test the thesis against price action, earnings dates, subsequent 13D/G filings, and the next 13F. The value is in building a repeatable map of behavior, not in assuming the disclosed book is still identical today.

For watchlist work, the practical next step is simple: flag the changed top-ten names, revisit them after the next quarterly filing, and compare the direction against other active holders. Agreement across filers deserves more attention than one isolated line item.